ADM Total Current Liabilities

Archer Daniels Midland · Total Current Liabilities

ADM logo

ADM Total Current Liabilities

Latest reported$20.01B
ADM Quarterly Current Liabilities ($363.20M → $20.01B)
High-resolution chart · PNG

ADM total current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Archer Daniels Midland Total Current Liabilities — Quarterly (USD)
Period endingTotal Current Liabilities (USD)
20,012,000,000
22,879,000,000
19,534,000,000
19,268,000,000
18,471,000,000
20,171,000,000
19,938,000,000
19,003,000,000
18,684,000,000
19,730,000,000
18,662,000,000
18,105,000,000
18,788,000,000
22,730,000,000
24,191,000,000
22,936,000,000
25,660,000,000
28,523,000,000
21,948,000,000
18,576,000,000
17,296,000,000
18,512,000,000
18,182,000,000
13,907,000,000
12,809,000,000
17,317,000,000
13,734,000,000
12,020,000,000
12,602,000,000
13,361,000,000
11,776,000,000
11,648,000,000
11,718,000,000
13,285,000,000
12,570,000,000
11,873,000,000
11,421,000,000
13,602,000,000
13,173,000,000
12,737,000,000
13,778,000,000
12,867,000,000
13,505,000,000
14,130,000,000
12,859,000,000
14,235,000,000
15,602,000,000
13,751,000,000
11,891,000,000
13,456,000,000
15,658,000,000
13,753,000,000
13,123,000,000
16,142,000,000
17,562,000,000
14,626,000,000
14,794,000,000
14,829,000,000
14,479,000,000
13,218,000,000
16,863,000,000
18,063,000,000
12,235,000,000
8,833,000,000
9,236,000,000
9,600,000,000
8,547,000,000
8,885,000,000
9,411,000,000
11,101,000,000
12,101,000,000
14,621,000,000
15,885,000,000
14,561,000,000
11,526,000,000
7,868,000,000
8,301,556,000
8,982,574,000
6,416,687,000
6,164,767,000
6,159,085,000
5,981,733,000
5,857,805,000
5,367,000,000
5,460,878,000
5,793,611,000
6,138,694,000
6,750,237,000
8,035,564,000
7,242,308,000
5,481,256,000
5,147,472,000
5,966,462,000
6,332,483,000
6,003,512,000
4,719,297,000
4,638,749,000
4,599,732,000
4,016,659,000
3,866,981,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.